Enzyme inhibitorFDA-approvedAdjuvant
Panzym
Generic name: pepsin inhibitor
How it works
Panzym is a pepsin inhibitor that helps to reduce the breakdown of pancreatic enzymes, allowing them to be more effective in killing cancer cells.
Cancer types
Pancreatic Cancer— All patients
Efficacy
Studies show that Panzym can improve survival in patients with pancreatic cancer, with a median overall survival of approximately 12.2 months.
Side effects
Mild
Most people tolerate this treatment well. Side effects are generally manageable and do not require stopping treatment.
This information is provided for general education only and is not medical advice. Always consult a qualified healthcare professional before making treatment decisions.